Literature DB >> 2772443

Statistical analysis of the stages of HIV infection using a Markov model.

I M Longini1, W S Clark, R H Byers, J W Ward, W W Darrow, G F Lemp, H W Hethcote.   

Abstract

We use a staged Markov model to estimate the distribution and mean length of the incubation period for acquired immunodeficiency syndrome (AIDS) from a cohort of 603 human immunodeficiency virus (HIV) infected individuals who have been followed through various stages of infection. The model partitions the infected period into four progressive stages: (1) infected but antibody-negative; (2) antibody-positive but asymptomatic; (3) pre-AIDS symptoms and/or abnormal haematologic indicator; and (4) clinical AIDS. We also model a fifth stage: death due to AIDS. The estimated mean (median) waiting times in each stage of infection are stage 1, 2.2 (1.5) months; stage 2, 52.6 (36.5) months; stage 3, 62.9 (43.6) months; and stage 4, 23.6(16.3) months. We estimate the mean AIDS incubation period (from infection to development of clinical AIDS) as 9.8 years with a 95 per cent confidence interval of [8.4, 11.2] years. The paper also considers the estimated density function of the AIDS incubation period and the estimated survival functions for individuals in each stage of infection. This work represents one of the most complete statistical descriptions to date of the natural history of HIV infection.

Entities:  

Mesh:

Year:  1989        PMID: 2772443     DOI: 10.1002/sim.4780080708

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  31 in total

1.  Multi-state models in epidemiology.

Authors:  D Commenges
Journal:  Lifetime Data Anal       Date:  1999-12       Impact factor: 1.588

2.  Design of panel studies for disease progression with multiple stages.

Authors:  Wei-Ting Hwang; Ron Brookmeyer
Journal:  Lifetime Data Anal       Date:  2003-09       Impact factor: 1.588

3.  Modeling Disease Progression with Longitudinal Markers.

Authors:  Lurdes Y T Inoue; Ruth Etzioni; Christopher Morrell; Peter Müller
Journal:  J Am Stat Assoc       Date:  2008       Impact factor: 5.033

4.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

5.  A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data.

Authors:  Jane M Lange; Rebecca A Hubbard; Lurdes Y T Inoue; Vladimir N Minin
Journal:  Biometrics       Date:  2014-10-15       Impact factor: 2.571

6.  HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington.

Authors:  Susan Cassels; Timothy W Menza; Steven M Goodreau; Matthew R Golden
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

7.  The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.

Authors:  Gregory S Zaric; Ahmed M Bayoumi; Margaret L Brandeau; Douglas K Owens
Journal:  Med Decis Making       Date:  2008-03-18       Impact factor: 2.583

8.  Optimal investment in HIV prevention programs: more is not always better.

Authors:  Margaret L Brandeau; Gregory S Zaric
Journal:  Health Care Manag Sci       Date:  2009-03

9.  Nonparametric inference and uniqueness for periodically observed progressive disease models.

Authors:  Beth Ann Griffin; Stephen W Lagakos
Journal:  Lifetime Data Anal       Date:  2009-07-23       Impact factor: 1.588

10.  HIV risk among Latino adolescents in two New England cities.

Authors:  K W Smith; S A McGraw; S L Crawford; L A Costa; J B McKinlay
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.